In a 68-year-old woman with type 2 diabetes mellitus, hypertension, and end-stage renal disease on hemodialysis presenting with dyspnea, elevated jugular venous pressure, and bilateral lower extremity edema, which ECG finding is most likely?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Peaked T Wave is the Most Likely ECG Finding

In this 68-year-old woman with end-stage renal disease on hemodialysis presenting with dyspnea and volume overload, the most likely ECG finding is peaked T waves (Answer A), which are the hallmark electrocardiographic manifestation of hyperkalemia—a common and life-threatening complication in dialysis patients.

Clinical Reasoning

This patient's presentation strongly suggests hyperkalemia as the underlying electrophysiological disturbance:

High-Risk Profile for Hyperkalemia

  • End-stage renal disease on hemodialysis: Patients with ESRD have impaired potassium excretion and are at markedly increased risk for hyperkalemia 1
  • Type 2 diabetes mellitus: Increases hyperkalemia risk through multiple mechanisms 1
  • Missed or inadequate dialysis: The clinical presentation of volume overload (high JVP, +3 edema, dyspnea) suggests inadequate dialysis or fluid removal, which allows potassium accumulation 2

ECG Manifestations of Hyperkalemia

Peaked T waves are the earliest and most characteristic ECG finding in hyperkalemia 1, 3:

  • Typically appear when potassium levels reach 5.5-6.5 mEq/L 3
  • Described as tall, narrow, and symmetric T waves
  • Most commonly observed ECG change in hyperkalemia 1

Progressive ECG changes with worsening hyperkalemia follow this sequence 3:

  1. Peaked T waves (5.5-6.5 mmol/L) - Most likely in this patient
  2. PR interval prolongation (6.5-7.5 mmol/L)
  3. QRS widening (7.0-8.0 mmol/L) - NOT narrow QRS
  4. Sine wave pattern, ventricular fibrillation, or asystole (>10 mmol/L)

Why Other Options Are Incorrect

B. Peaked P Wave

  • Not associated with hyperkalemia or volume overload
  • Would suggest right atrial enlargement from chronic pulmonary disease
  • Not relevant to this clinical scenario

C. Short PR Interval

  • Suggests pre-excitation syndromes (e.g., Wolff-Parkinson-White)
  • Hyperkalemia causes PR prolongation, not shortening 3
  • Unrelated to ESRD or volume overload

D. Narrow QRS Complex

  • Directly contradicts hyperkalemia, which causes QRS widening 1, 3
  • As hyperkalemia progresses, QRS complexes become wider, not narrower
  • This option is the opposite of expected findings

Critical Clinical Considerations

Hyperkalemia in Dialysis Patients

Dialysis patients face unique hyperkalemia risks 2, 4:

  • Arrhythmias often occur during hemodialysis sessions and for 4-5 hours afterward 2
  • Hemodynamic status and electrolyte fluctuations (potassium, magnesium, calcium) play crucial roles 2
  • Risk factors include left ventricular hypertrophy, hypertension, cardiac dysfunction, and underlying coronary disease 2

Important Caveats

ECG findings in hyperkalemia are highly variable 1, 3:

  • Not all patients follow the classic progression
  • ECG changes may not be predictable among individuals 3
  • Some patients with severe hyperkalemia may have minimal ECG changes 1
  • Laboratory confirmation is essential—ECG is not as sensitive as serum potassium measurement for predicting hyperkalemia 1

Immediate Management Priorities

When hyperkalemia is suspected in this clinical context 1:

  1. Obtain stat serum potassium level (laboratory test is more sensitive than ECG)
  2. Continuous ECG monitoring for arrhythmia detection
  3. Assess hemodynamic status and electrolyte balance (potassium, magnesium, calcium) 2
  4. Prepare for acute hyperkalemia treatment if confirmed:
    • IV calcium gluconate (cardiac membrane stabilization within 1-3 minutes) 1
    • Insulin/glucose and inhaled β-agonists (shift potassium intracellularly within 30 minutes) 1
    • Urgent hemodialysis for definitive potassium removal in ESRD patients 1

Additional Differential Consideration

While hyperkalemia is most likely, this patient's presentation also raises concern for volume overload and possible heart failure exacerbation 5:

  • High JVP is the most reliable sign of volume overload 5
  • Bilateral lower extremity edema with jugular venous distention suggests elevated right-sided filling pressures 5
  • However, the ECG question specifically points toward the electrolyte abnormality (hyperkalemia) rather than structural heart disease

The combination of ESRD, inadequate dialysis, and volume overload makes peaked T waves from hyperkalemia the most likely ECG finding in this patient 1, 2, 3.

Related Questions

What is the most likely cause of sudden respiratory and cardiac arrest in an end‑stage renal disease patient after two hours of hemodialysis when initial labs, electrocardiogram, and brain CT are normal?
What are the causes of sudden cardiac death in a patient with severe uremia who has not yet started dialysis?
Do small pericardial effusions commonly occur in patients with uremic pericarditis?
What is the optimal medical management of pericardial effusion in a patient with acute renal failure?
Can fluid volume overload in a patient with renal failure precipitate uremic pericarditis?
What is the most effective regimen for rapidly reducing facial oiliness, comparing oral isotretinoin (0.5–1 mg/kg daily), oral spironolactone (100 mg nightly), and topical retinoids (adapalene 0.1% or tretinoin 0.025–0.05%) with adjunctive benzoyl peroxide or niacinamide?
In a patient taking amiodarone who has a TSH level of 7.18 mIU/L, what does this indicate and how should it be managed?
What is the recommended dosing and duration of amoxicillin and levofloxacin (with a proton‑pump inhibitor) for treating Helicobacter pylori infection, and what contraindications or alternative regimens should be considered?
What volume of 5% albumin should be used as replacement fluid during therapeutic plasma exchange for a 70‑kg adult lung‑transplant recipient?
What is the therapeutic plasma exchange protocol for a 70‑kg lung transplant recipient?
What is the recommended duration of alendronate therapy for osteoporosis and the criteria for initiating a drug holiday?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.